New Funding Opportunities to Investigate Cellular Senescence!

From the NIA Division of Aging Biology

Contacts are [email protected] (Felipe Sierra, NIA) and [email protected] (Kevin Howcroft, NCI).

Application due dates are March 8, 2021.

The NIH Common Fund has issued three funding opportunity announcements (FOAs) to support the new Cellular Senescence Network (SenNet) program. The program aims to catalyze the development of a framework for mapping cellular senescence and its associated secretory phenotype at high resolution, and to provide atlases of cellular senescence in multiple tissues across various states of human health, and across the lifespan. In addition, it is expected that the SenNet will provide comprehensive sets of biomarkers describing heterogenous senescent cell states.

In these FOAs, NIH is calling for applications in the following areas:

Pre-application Webinar: NIH Common Fund staff will host an interactive pre-application webinar to discuss frequently asked questions as well as any other applicant queries on January 22, 2021, from 12:00-1:30 P.M. (EST). A recording of the webinar will not be posted online, but the slides and resultant Frequently Asked Questions (FAQs) will be posted on the SenNet webpage. Please direct inquiries to [email protected]. Webinar details are below:

https://nih.webex.com/nih/j.php?MTID=m9973369e640ca91c668b246542538191

Meeting number: 126 463 3177

Password: Senescence

Join by video system

Dial [email protected]

You can also dial 173.243.2.68 and enter your meeting number.

Join by phone

1-650-479-3208 Call-in toll number (US/Canada)

Access code: 126 463 3177

Application Due Dates: Applications for each FOA are due March 8, 2021. Additional details about the program will be posted on the SenNet webpage as they become available.

We encourage you to share this email with any interested colleagues.

About the NIH Common Fund: The NIH Common Fund encourages collaboration and supports a series of exceptionally high-impact, trans-NIH programs. Common Fund programs are managed by the Office of Strategic Coordination in the Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director in partnership with the NIH Institutes, Centers, and Offices. More information is available at the Common Fund website: https://commonfund.nih.gov.

RFA-CA-20-040 – Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)

For those who might be interested in submitting an application to RFA-CA-20-040 in which NIA is an equal partner, please see this notice.

Informational Webinar scheduled for Sep 18.

Questions ahead of Webinar due Sep 14.

The lead contact for NIA is Candace Kerr, Ph.D.
Email: [email protected]

Pre-Application Webinar for RFA-CA-20-040, Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)

Notice Number: NOT-CA-20-105

Key Dates

Release Date: September 8, 2020

Related Announcements

RFA-CA-20-040 – Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)

Issued by National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on September 18, 2020, from 1:00 – 2:00 PM (ET) for the Funding Opportunity Announcement (FOA) RFA-CA-20-040 titled “Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)”.

NCI and National Institute on Aging (NIA) staff members involved in the FOA will provide a brief overview of the RFA-CA-20-040 for potential applicants by explaining the goals and objectives for the FOA, as well as answering questions from webinar attendees.

Please submit questions by September 14, 2020 to [email protected]. Attendees will also be able to submit questions during the webinar. Questions submitted early will be answered first.

Join the webinar or copy and paste the following Webex link into your browser: https://cbiit.webex.com/cbiit/j.php?MTID=m6a7b73daaa815f0601174dbebb02345c

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-20-040. A document highlighting frequently asked questions and corresponding answers will be posted to the NCI Division of Cancer Biology FOA website following the webinar.

Please direct all inquiries to:

Margaret Klauzinska, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5181
Email: [email protected]

Candace Kerr, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-827-4474
Email: [email protected]